SILENCING INFLAMMATORY SIGNALS IN CHONDROCYTES BY CRISPR/CAS9 FOR TISSUE ENGINEERED CELL THERAPY IN OSTEOARTHRITIS. (April 2022) - Bonato, A.; Barreto, G.; Fisch, P.; Fercher, D.; Zenobi-Wong, M.